Skip to main content
Clinical Trials/JPRN-UMIN000029418
JPRN-UMIN000029418
Completed
未知

Exporatory clinical study for newly developed drug therapy for preeclampsia with oral nicotinamide - Exporatory clinical study for preeclampsia with oral nicotinamide

Tohoku University0 sites6 target enrollmentOctober 4, 2017
Conditionspreeclampsia

Overview

Phase
未知
Intervention
Not specified
Conditions
preeclampsia
Sponsor
Tohoku University
Enrollment
6
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 4, 2017
End Date
March 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)pulmonary edema 2\)HELLP syndrome 3\)non reasuring fetal status 4\)estimated fetal body weight\<1\.5SD oligohydramnios: maximum vertical pocket\<2cm intermittent or retrograde umbilical blood flow 5\)genital bleeding of unknown origin 6\)progression of premature labor 7\)allegey for nicotinamide 8\)dangerous situations for mother or fetus evaluated by doctors

Outcomes

Primary Outcomes

Not specified

Similar Trials